Login / Signup

Long-acting reversible contraception by effervescent microneedle patch.

Wei LiJie TangRichard N TerrySong LiAurelie BrunieRebecca L CallahanRichard K NoelCarlos A RodríguezSteven P SchwendemanMark R Prausnitz
Published in: Science advances (2019)
To increase access to long-acting contraception, we developed a reversible contraceptive microneedle patch that is simple-to-administer, slowly releases contraceptive hormone (levonorgestrel) for >1 month, and generates no biohazardous sharps waste. After manually pressing the patch to skin for 1 min, microneedles rapidly separate from the patch within the skin due to effervescence triggered by contact with skin's interstitial fluid, as demonstrated in rats and human participants. Long-acting contraception is achieved by formulating microneedles with a biodegradable polymer [poly(lactic-co-glycolic) acid] that slowly releases levonorgestrel for ~1 month in vitro. In rats, the patch maintained levonorgestrel concentration above the human contraceptive threshold level for >1 month, and a placebo microneedle patch was well-tolerated in human participants. Women of reproductive age in three continents demonstrated interest in and preference for long-acting contraception by microneedle patch. These studies indicate that an effervescent microneedle patch could facilitate greater access to long-acting contraception.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • drug delivery
  • pluripotent stem cells
  • type diabetes
  • randomized controlled trial
  • soft tissue
  • wound healing
  • clinical trial
  • heavy metals
  • insulin resistance